https://stock.noler.com/us/stock/sqz-biotechnologies-company https://stock.noler.com/us/stock/sqz-biotechnologies-company/accounts-payable https://stock.noler.com/us/stock/sqz-biotechnologies-company/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/sqz-biotechnologies-company/accrued-employee-benefits-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/accrued-liabilities-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/accumulated-depreciation https://stock.noler.com/us/stock/sqz-biotechnologies-company/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sqz-biotechnologies-company/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sqz-biotechnologies-company/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/sqz-biotechnologies-company/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/sqz-biotechnologies-company/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/aoci https://stock.noler.com/us/stock/sqz-biotechnologies-company/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/sqz-biotechnologies-company/available-for-sale-debt-securities https://stock.noler.com/us/stock/sqz-biotechnologies-company/basic-shares https://stock.noler.com/us/stock/sqz-biotechnologies-company/buybacks-share-repurchases https://stock.noler.com/us/stock/sqz-biotechnologies-company/capital-expenditures https://stock.noler.com/us/stock/sqz-biotechnologies-company/cash-and-equivalents https://stock.noler.com/us/stock/sqz-biotechnologies-company/cash-and-restricted-cash https://stock.noler.com/us/stock/sqz-biotechnologies-company/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sqz-biotechnologies-company/cash-flow-breakdown https://stock.noler.com/us/stock/sqz-biotechnologies-company/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sqz-biotechnologies-company/common-stock-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/comprehensive-income https://stock.noler.com/us/stock/sqz-biotechnologies-company/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sqz-biotechnologies-company/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/sqz-biotechnologies-company/cover-page-shares-outstanding https://stock.noler.com/us/stock/sqz-biotechnologies-company/cumulative-earnings-deficit https://stock.noler.com/us/stock/sqz-biotechnologies-company/current-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/current-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-costs https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-income-tax-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-offering-costs https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-revenue https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-revenue-noncurrent https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-revenue-recognized https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-net https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-other https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/sqz-biotechnologies-company/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/sqz-biotechnologies-company/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/depreciation-and-amortization https://stock.noler.com/us/stock/sqz-biotechnologies-company/diluted-shares https://stock.noler.com/us/stock/sqz-biotechnologies-company/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sqz-biotechnologies-company/effective-tax-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/eps https://stock.noler.com/us/stock/sqz-biotechnologies-company/eps-basic https://stock.noler.com/us/stock/sqz-biotechnologies-company/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/financing-cash-flow https://stock.noler.com/us/stock/sqz-biotechnologies-company/form-d-stocks https://stock.noler.com/us/stock/sqz-biotechnologies-company/furniture-and-fixtures-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/sqz-biotechnologies-company/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/sqz-biotechnologies-company/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/sqz-biotechnologies-company/income-loss-from https://stock.noler.com/us/stock/sqz-biotechnologies-company/income-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/increase-decrease-in-restructuring-reserve https://stock.noler.com/us/stock/sqz-biotechnologies-company/insider-transactions-other https://stock.noler.com/us/stock/sqz-biotechnologies-company/insider-transactions-preferred https://stock.noler.com/us/stock/sqz-biotechnologies-company/insider-transactions-stock-options https://stock.noler.com/us/stock/sqz-biotechnologies-company/interest-receivable-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/investing-cash-flow https://stock.noler.com/us/stock/sqz-biotechnologies-company/investment-income-interest https://stock.noler.com/us/stock/sqz-biotechnologies-company/lease-cost https://stock.noler.com/us/stock/sqz-biotechnologies-company/leasehold-improvements-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/machinery-and-equipment-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/marketable-securities https://stock.noler.com/us/stock/sqz-biotechnologies-company/marketable-securities-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/net-income https://stock.noler.com/us/stock/sqz-biotechnologies-company/net-income-loss-including-portion-attributable-to-nonredeemable-noncontrolling-interest https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-available-for-sale-adjustment-before-reclassification-adjustments-and-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-net-of-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-reclassification-adjustment-for-held-to-maturity-transferred-to-available-for-sale-before-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-before-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-cash-flow https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-expenses https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-income https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-cost https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-impairment-loss https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-liability https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-liability-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/sqz-biotechnologies-company/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-accrued-liabilities-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-income https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-noncurrent-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-noncurrent-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-nonoperating-income-expense https://stock.noler.com/us/stock/sqz-biotechnologies-company/other-receivables-net-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/payments-for-repurchase-of-convertible-preferred-stock https://stock.noler.com/us/stock/sqz-biotechnologies-company/payments-for-restructuring https://stock.noler.com/us/stock/sqz-biotechnologies-company/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sqz-biotechnologies-company/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/sqz-biotechnologies-company/preferred-shares-facts https://stock.noler.com/us/stock/sqz-biotechnologies-company/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sqz-biotechnologies-company/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sqz-biotechnologies-company/preferred-stock-shares-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sqz-biotechnologies-company/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/prepaid-expense-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-stock-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/sqz-biotechnologies-company/profit-loss https://stock.noler.com/us/stock/sqz-biotechnologies-company/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/property-plant-equipment https://stock.noler.com/us/stock/sqz-biotechnologies-company/provision-for-doubtful-accounts https://stock.noler.com/us/stock/sqz-biotechnologies-company/public-float https://stock.noler.com/us/stock/sqz-biotechnologies-company/receivables-net-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/research-and-development https://stock.noler.com/us/stock/sqz-biotechnologies-company/restricted-cash https://stock.noler.com/us/stock/sqz-biotechnologies-company/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/sqz-biotechnologies-company/restricted-cash-noncurrent https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-charges https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-costs https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-reserve https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-reserve-current https://stock.noler.com/us/stock/sqz-biotechnologies-company/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/sqz-biotechnologies-company/retained-earnings https://stock.noler.com/us/stock/sqz-biotechnologies-company/revenue https://stock.noler.com/us/stock/sqz-biotechnologies-company/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/sqz-biotechnologies-company/revenue-not-from-contract-with-customer https://stock.noler.com/us/stock/sqz-biotechnologies-company/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sqz-biotechnologies-company/sga-expense https://stock.noler.com/us/stock/sqz-biotechnologies-company/shareholders-equity https://stock.noler.com/us/stock/sqz-biotechnologies-company/shares-authorized https://stock.noler.com/us/stock/sqz-biotechnologies-company/shares-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/short-term-lease-cost https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-based-compensation https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-exercisable-number https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-outstanding-number https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/sqz-biotechnologies-company/stock-split-ratio https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/sqz-biotechnologies-company/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-shares-authorized https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-shares-issued https://stock.noler.com/us/stock/sqz-biotechnologies-company/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/sqz-biotechnologies-company/total-assets https://stock.noler.com/us/stock/sqz-biotechnologies-company/total-contract-liability https://stock.noler.com/us/stock/sqz-biotechnologies-company/total-liabilities https://stock.noler.com/us/stock/sqz-biotechnologies-company/total-liabilities-and-equity https://stock.noler.com/us/stock/sqz-biotechnologies-company/unrecognized-tax-benefits https://stock.noler.com/us/stock/sqz-biotechnologies-company/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/sqz-biotechnologies-company/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/sqz-biotechnologies-company/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sqz-biotechnologies-company/variable-lease-cost https://stock.noler.com/us/stock/sqz-biotechnologies-company/weighted-average-number-of-share-outstanding-basic-and-diluted